United States · General news · New York Post

Big, fat demand for weight-loss drugs fuels Eli Lilly stock surge — as market cap hits $1.2 trillion

Published by New York Post · United States 1 h ago

Eli Lilly stock hit a record high Thursday thanks to a stronger-than-expected earnings report fueled by sales of weight loss drugs Monjuaro and Zepbound.

Read the full article on New York Post Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (nypost.com)

Also worth reading

Mongabay

Big, fat demand for weight-loss drugs fuels Eli Lilly stock surge — as market cap hits $1.2 trillion

Share

Also worth reading

Zambia’s edible insect tradition offers a potential boost to food security

CNN, MSNOW and Politico ask court to make Trump access order permanent

Vance undecided on whether Peltola should be prosecuted

Items found in Pompeii home hint at life before volcanic explosion

Barbara Barrie, Oscar-nominated actor, dies with medical assistance at 95

Charlie Kirk’s final endorsement is on the ropes — despite his group’s big push